Senate grants the FDA a 6.5% raise in funding

Share this article:
The FDA's total funding for FY 2007 has been set at $1.942 billion--representing a 6.5%
increase over the previous year. The Senate Appropriations Committee reported out the agency's spending provision as part of the agriculture appropriations bill.

The measure includes “increases of $50.5 million for pandemic avian influenza preparedness, $8.6 million for medical device and animal drug review, $4.0 million for drug safety, $5.5 million for food safety, $10.0 million for generic drug review, $5.9 million for the Critical Path initiative, and $2.5 million for human tissue safety,” a committee release said.

It noted that the bill does not include language addressing the FDA's authority to require post-marketing studies of drugs, a provision dropped by the House when it passed its version in May.

The bill does, however, include language representing a compromise agreement requiring the FDA to provide advance notification about conflicts of interest waivers granted to outside experts impaneled as “special government employees” on FDA advisory committees, 15 days prior to committee meetings.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.